Kristy Hernandez, Kimberlee Fisher, and Leah Scott have filed three separate lawsuits in St. Louis Circuit Court against Lexapro manufacturer Forest Laboratories and Forest Pharmaceuticals alleging the drug maker knew about the danger to unborn children whose mother used Lexapro during pregnancy and still promoted the drug towards expectant mothers and women of childbearing age.
According to their lawsuits, each plaintiff used the anti-depressant Lexapro during their pregnancies, and each of them had a child born with a birth defect. Fisher’s daughter Isabella was born with spina bifida, Hernandez’ daughter was born with a clubbed foot, and Scott’s son was born with a bilateral cleft lip and palette.
The lawsuits allege that Forest failed to warn consumers about the risks of the drug, as well as breached its implied and express warranty by promoted the drug as safe for pregnant women. The complaints also accuse Forest of fraud for denying that the drug had any connection to the birth defects.
“In flagrant and conscious disregard and indifference, Forest Defendants have denied publicly that any connection between Lexapro and birth defects exists, and have failed utterly to take any measures whatsoever to alert the public, the prescribing physicians, and the patients who take it, of the incipient dangers associated with Lexapro,” the Madison Record reports the lawsuits as saying.
The lawsuits seek general damages, medical costs, pre-and post judgment interest, as well as punitive and exemplary damages, and any other relief the courts deems reasonable and just.